Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-16 11:45 am Sale | 2023-12-31 | 13G | Verve Therapeutics, Inc. VERV | SINGER JAMES R | 3,000,000 3.700% | -2,000,000 (-40.00%) | Filing History |
| 2023-12-11 4:16 pm Purchase | 2023-12-01 | 13G | Verve Therapeutics, Inc. VERV | GV 2017, L.P. | 12,349,086 15.400% | 12,349,086 (New Position) | Filing History |
| 2023-12-11 09:09 am Sale | 2023-12-08 | 13G | Verve Therapeutics, Inc. VERV | FMR LLC | 3,803,214 4.842% | -3,102,208 (-44.92%) | Filing History |
| 2023-02-14 10:40 am Purchase | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | SINGER JAMES R | 5,000,000 8.100% | 2,535,000 (+102.84%) | Filing History |
| 2023-02-13 9:27 pm Sale | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | Casdin Capital LLC | 2,290,571 3.700% | -847,596 (-27.01%) | Filing History |
| 2023-02-13 4:08 pm Sale | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | ARCH Venture Fund X L.P. | 0 0.000% | -2,508,809 (Position Closed) | Filing History |
| 2023-02-10 4:05 pm Sale | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | GV 2017, L.P. | 10,549,086 17.100% | -424,925 (-3.87%) | Filing History |
| 2023-02-10 2:56 pm Purchase | 2022-12-31 | 13G | Farmers & Merchants Bancorp, Inc. FMAO | BlackRock Inc. BLK | 3,594,074 5.800% | 3,594,074 (New Position) | Filing History |
| 2023-02-10 2:33 pm Purchase | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | ARK Investment Management LLC | 4,365,830 7.090% | 4,365,830 (New Position) | Filing History |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Verve Therapeutics, Inc. VERV | FMR LLC | 6,905,422 11.209% | 511,609 (+8.00%) | Filing History |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | Verve Therapeutics, Inc. VERV | The Vanguard Group | 3,812,024 6.190% | 3,812,024 (New Position) | Filing History |
| 2023-02-07 1:11 pm Purchase | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | STATE STREET CORP STT | 4,471,049 7.260% | 4,471,049 (New Position) | Filing History |
| 2023-02-06 2:58 pm Sale | 2022-12-30 | 13G | Verve Therapeutics, Inc. VERV | Wellington Management Group LLP | 859,102 1.390% | -3,080,406 (-78.19%) | Filing History |
| 2022-08-10 08:10 am Purchase | 2022-08-09 | 13G | Verve Therapeutics, Inc. VERV | FMR LLC | 6,393,813 10.976% | 1,392,331 (+27.84%) | Filing History |
| 2022-02-14 5:15 pm Purchase | 2021-12-31 | 13G | Verve Therapeutics, Inc. VERV | GV 2017, L.P. | 10,974,011 22.780% | 10,974,011 (New Position) | Filing History |
| 2022-02-14 09:27 am Purchase | 2021-12-31 | 13G | Verve Therapeutics, Inc. VERV | Casdin Capital LLC | 3,138,167 6.500% | 100,000 (+3.29%) | Filing History |
| 2022-02-09 1:26 pm Purchase | 2021-12-31 | 13G | Verve Therapeutics, Inc. VERV | ARCH Venture Fund X L.P. | 2,508,809 5.200% | 2,508,809 (New Position) | Filing History |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | Verve Therapeutics, Inc. VERV | FMR LLC | 5,001,482 10.382% | 159,757 (+3.30%) | Filing History |
| 2022-02-04 09:24 am Purchase | 2021-12-31 | 13G | Verve Therapeutics, Inc. VERV | Wellington Management Group LLP | 3,939,508 8.180% | 3,939,508 (New Position) | Filing History |
| 2022-02-04 08:53 am Sale | 2021-12-31 | 13G | Verve Therapeutics, Inc. VERV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 1,871,679 3.890% | -623,892 (-25.00%) | Filing History |